Literature DB >> 28516376

An Update on the Approach to the Imaging of Brain Tumors.

Katherine M Mullen1, Raymond Y Huang2.   

Abstract

PURPOSE OF REVIEW: Neuroimaging plays a critical role in diagnosis of brain tumors and in assessment of response to therapy. However, challenges remain, including accurately and reproducibly assessing response to therapy, defining endpoints for neuro-oncology trials, providing prognostic information, and differentiating progressive disease from post-therapeutic changes particularly in the setting of antiangiogenic and other novel therapies. RECENT
FINDINGS: Recent advances in the imaging of brain tumors include application of advanced MRI imaging techniques to assess tumor response to therapy and analysis of imaging features correlating to molecular markers, grade, and prognosis. This review aims to summarize recent advances in imaging as applied to current diagnostic and therapeutic neuro-oncologic challenges.

Entities:  

Keywords:  Diffusion; Glioma; MRI; Perfusion; Pet; Spectroscopy

Mesh:

Year:  2017        PMID: 28516376     DOI: 10.1007/s11910-017-0760-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  100 in total

Review 1.  A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors.

Authors:  C Zhao; Y Zhang; J Wang
Journal:  AJNR Am J Neuroradiol       Date:  2013-09-12       Impact factor: 3.825

2.  Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.

Authors:  Hee Ho Chu; Seung Hong Choi; Inseon Ryoo; Soo Chin Kim; Jeong A Yeom; Hwaseon Shin; Seung Chai Jung; A Leum Lee; Tae Jin Yoon; Tae Min Kim; Se-Hoon Lee; Chul-Kee Park; Ji-Hoon Kim; Chul-Ho Sohn; Sung-Hye Park; Il Han Kim
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

3.  Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI.

Authors:  Benjamin M Ellingson; Albert Lai; Huytram N Nguyen; Phioanh L Nghiemphu; Whitney B Pope; Timothy F Cloughesy
Journal:  Clin Cancer Res       Date:  2015-04-21       Impact factor: 12.531

4.  Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.

Authors:  Philipp Kickingereder; David Bonekamp; Martha Nowosielski; Annekathrin Kratz; Martin Sill; Sina Burth; Antje Wick; Oliver Eidel; Heinz-Peter Schlemmer; Alexander Radbruch; Jürgen Debus; Christel Herold-Mende; Andreas Unterberg; David Jones; Stefan Pfister; Wolfgang Wick; Andreas von Deimling; Martin Bendszus; David Capper
Journal:  Radiology       Date:  2016-09-16       Impact factor: 11.105

5.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

Authors:  Quinn T Ostrom; Haley Gittleman; Peter Liao; Chaturia Rouse; Yanwen Chen; Jacqueline Dowling; Yingli Wolinsky; Carol Kruchko; Jill Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

6.  ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.

Authors:  Dong-Li Li; Yi-Kai Xu; Quan-Shi Wang; Hu-Bing Wu; Hong-Sheng Li
Journal:  Chin Med J (Engl)       Date:  2012-01       Impact factor: 2.628

7.  Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers.

Authors:  Rajan Jain; Laila Poisson; Jayant Narang; David Gutman; Lisa Scarpace; Scott N Hwang; Chad Holder; Max Wintermark; Rivka R Colen; Justin Kirby; John Freymann; Daniel J Brat; Carl Jaffe; Tom Mikkelsen
Journal:  Radiology       Date:  2012-12-13       Impact factor: 11.105

8.  O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.

Authors:  Markus Hutterer; Martha Nowosielski; Daniel Putzer; Dietmar Waitz; Gerd Tinkhauser; Herwig Kostron; Armin Muigg; Irene J Virgolini; Wolfgang Staffen; Eugen Trinka; Thaddäus Gotwald; Andreas H Jacobs; Guenther Stockhammer
Journal:  J Nucl Med       Date:  2011-06       Impact factor: 10.057

9.  Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.

Authors:  Kathleen M Schmainda; Zheng Zhang; Melissa Prah; Bradley S Snyder; Mark R Gilbert; A Gregory Sorensen; Daniel P Barboriak; Jerrold L Boxerman
Journal:  Neuro Oncol       Date:  2015-02-02       Impact factor: 12.300

10.  Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data.

Authors:  Wentian Guo; Hui Li; Yitan Zhu; Li Lan; Shengjie Yang; Karen Drukker; Elizabeth Morris; Elizabeth Burnside; Gary Whitman; Maryellen L Giger; Yuan Ji
Journal:  J Med Imaging (Bellingham)       Date:  2015-09-23
View more
  5 in total

1.  PET Use in Cancer Diagnosis, Treatment, and Prognosis.

Authors:  Naresh Damuka; Meghana Dodda; Kiran Kumar Solingapuram Sai
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology.

Authors:  Benjamin B Kasten; Neha Udayakumar; Jianmei W Leavenworth; Anna M Wu; Suzanne E Lapi; Jonathan E McConathy; Anna G Sorace; Asim K Bag; James M Markert; Jason M Warram
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

3.  Characterizing Brain Tumor Regions Using Texture Analysis in Magnetic Resonance Imaging.

Authors:  Yun Yu; Xi Wu; Jiu Chen; Gong Cheng; Xin Zhang; Cheng Wan; Jie Hu; Shumei Miao; Yuechuchu Yin; Zhongmin Wang; Tao Shan; Shenqi Jing; Wenming Wang; Jianjun Guo; Xinhua Hu; Yun Liu
Journal:  Front Neurosci       Date:  2021-06-03       Impact factor: 4.677

Review 4.  Intravoxel incoherent motion MRI in neurological and cerebrovascular diseases.

Authors:  André M Paschoal; Renata F Leoni; Antonio C Dos Santos; Fernando F Paiva
Journal:  Neuroimage Clin       Date:  2018-08-31       Impact factor: 4.881

5.  Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas.

Authors:  Peter Raab; Rouzbeh Banan; Arash Akbarian; Majid Esmaeilzadeh; Madjid Samii; Amir Samii; Helmut Bertalanffy; Ulrich Lehmann; Joachim K Krauss; Heinrich Lanfermann; Christian Hartmann; Roland Brüning
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.